高灵敏度和选择性的氨基安替比林基希夫碱对Fe2+的识别

以4-氨基安替比林与2-(4-甲基吡啶)-2-异烟酸醛缩合反应得到新型安替比林衍生物(E)-1,5-二甲基-4-((2-(4-甲基吡啶-2-基)吡啶-4-基)亚甲基氨基)-2-苯基-1,2-二氢吡唑-3-酮(L),并对其光学、金属离子选择性识别性能和单晶结构进行了研究。发现L在水-乙醇(9∶1,V/V)溶液中,能选择性比色和肉眼识别Fe~(2+),且受常见金属离子的干扰较小。用Job法得到Fe~(2+)与L的化学计量比为1∶3([FeL_3]~(2+)),配合物的缔合常数为3.70×1021 L3·mol-3,检测限为0.094μmol·L~(-1)。结果表明,化学传感器L可作为一种有选择性、灵敏的Fe~(2+)比色传感器。     

含多氟烷基吡唑环的邻甲酰氨基苯甲酰胺类化合物的合成及杀虫活性

以2,3-二氯吡啶和水合肼为起始原料,经取代、缩合、氧化、醚化、成环和开环等多步反应合成一系列结构新颖的含多氟烷基吡唑环的邻甲酰氨基苯甲酰胺类化合物,结构经1H NMR和HRMS确证,并测试了目标化合物的杀虫活性.杀虫活性结果表明,在浓度0.8 mg/L下,大部分化合物对粘虫(Mythimna separata Walker)具有100%杀虫活性;在浓度2 mg/L下,N-(4-氯-2-(异丙基氨基甲酰)-6-甲基苯基)-1-(3-氯吡啶-2-基)-3-((1-甲基-3-五氟乙基-4-三氟甲基-1H-吡唑-5-基)氧基)-1H-吡唑-5-酰胺(8c)和N-(4-氯-2-(环丙基氨基甲酰)-6-甲基苯基)-1-(3-氯吡啶-2-基)-3-((1-甲基-3-五氟乙基-4-三氟甲基-1H-吡唑-5-基)氧基)-1H-吡唑-5-酰胺(8d)对斜纹夜蛾(Prodenia litura Fabricius)杀虫活性大于60%;在浓度0.08 mg/L下,N-(4-氯-2-(二甲基氨基甲酰)-6-甲基苯基)-1-(3-氯吡啶-2-基)-3-((1-甲基-3-五氟乙基-4-三氟甲基-1H-吡唑-5-基)氧基)-1H-吡唑-5-酰胺(8l)对小菜蛾(Plutella xylostella Linnaeus)杀虫活性达到82.5%.     

新型2-(1-甲基-1H-吡唑-4-基)嘧啶-4-甲酰胺的设计、合成、杀菌活性及分子对接研究

为寻找结构新颖的嘧啶类杀菌剂,以2-氯嘧啶-4-甲酸、1-甲基-4-吡唑硼酸频哪醇酯、取代苯胺或取代苄胺等为原料,经Suzuki偶联和酰胺化反应合成了13种2-(1-甲基-1H-吡唑-4-基)嘧啶-4-甲酰胺类化合物,其结构经过1H NMR、13CNMR、IR、HRMS鉴定,并利用X射线单晶衍射法确定了N-苄基-2-(1-甲基-1H-吡唑-4-基)嘧啶-4-甲酰胺(4h)的晶体结构.初步测试了目标化合物对3种植物病原菌的杀菌活性,在浓度为100 mg/L时, N-(4-甲基苯基)-2-(1-甲基-1H-吡唑-4-基)嘧啶-4-甲酰胺(4f)和N-(4-氯苄基)-2-(1-甲基-1H-吡唑-4-基)嘧啶-4-甲酰胺(4j)对水稻纹枯菌表现出较高的杀菌活性,抑制率分别为85.3%和79.1%.分子对接研究显示4f可与琥珀酸脱氢酶活性腔内的氨基酸残基形成2个氢键和1个阳离子-π相互作用.     

含三氟甲基吡啶酰胺结构的N-氰基磺酰亚胺衍生物的合成及生物活性

采用活性亚结构拼接法,设计合成了系列新型含三氟甲基吡啶酰胺结构的N-氰基磺酰亚胺类衍生物,其结构经1H NMR、~(13)C NMR、~(19)F NMR和HRMS进行了表征.评估了它们对柑橘溃疡病菌(Xanthomonas axonopodis pv. citri)、烟草青枯病菌(Ralstoniasolanacearum)和水稻白叶枯病菌(Xanthomonasoryzaepv.oryzae)的杀菌活性及对小菜蛾(Plutella xylostella)的杀虫活性.结果表明,部分化合物表现出了良好的抗菌活性和中等的杀虫活性.其中,在200 mg/L质量浓度下,3-氯-(2-(N-氰基-S-(3,4-二氟苄基)磺酰亚胺酰基)乙基)-5-(三氟甲基)吡啶酰胺(G10)对柑橘溃疡病菌、烟草青枯病菌和水稻白叶枯病菌的抑制率分别为67%、53%和48%,3-氯-(2-(N-氰基-S-(2,5-二氟苄基)磺酰亚胺酰基)乙基)-5-(三氟甲基)吡啶酰胺(G17)对柑橘溃疡病菌的抗菌活性为69%,(2-(S-(2-溴-4-氟苄基)-N-氰基磺酰亚胺基)乙基)-3-氯-5-(三氟甲基)吡啶酰胺(G14)对水稻白叶枯病菌的抑制率为49%.在100 mg/L时,(2-(S-(4-溴-2-氟苄基)-N-氰基磺酰亚胺基)乙基)-3-氯-5-(三氟甲基)吡啶酰胺(G1)、3-氯-(2-(N-氰基-S-(3-氟苄基)磺酰亚胺基)乙基)-5-(三氟甲基)吡啶酰胺(G7)、3-氯-(2-(N-氰基-S-(2,4-二氟苄基)磺酰亚胺酰基)乙基)-5-(三氟甲基)吡啶酰胺(G8)和G10也有中等的杀菌活性,在测试浓度下,部分化合物的活性略高于对照药剂或与之相当.此外,在500mg/L时,化合物G10和3-氯-(2-(N-氰基-S-(4-异丙基苄基)磺酰亚胺基)乙基)-5-(三氟甲基)吡啶酰胺(G11)对小菜蛾的致死率分别为77%和70%.     

含叔醇结构的新型吡唑-4-甲酰胺类化合物的合成及杀菌活性

在吡唑环的3位引入叔醇结构,设计合成了一系列新颖的吡唑-4-甲酰胺类化合物,其结构经1H NMR, 13C NMR,HR-ESI-MS和X射线衍射表征确证.生物活性测试结果显示,部分化合物在100μg/mL时对瓜果腐霉菌和辣椒疫霉菌等测试植物病原菌显示了一定的杀菌活性,如N-(2-氟苯基)-3-(1-羟基环己基)-1,5-二甲基-1H-吡唑-4-甲酰胺(B1)和N-(噻唑-2-基)-3-(1-羟基环己基)-1,5-二甲基-1H-吡唑-4-甲酰胺(B10)对瓜果腐霉菌的EC50分别为76.3和71.9μg/mL,化合物B10对辣椒疫霉菌的EC50分别为85.4μg/mL.     

N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类新化合物的合成及生物活性

以N-吡啶基吡唑甲酸和2-氨基-3-甲基苯甲酸为起始原料,经由亲核加成、环化和酰化等多步反应合成了一系列结构新颖的N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类化合物.测试了所合成化合物的杀虫及抑菌活性,结果表明,新化合物大多化合物在200 mg·L^-1浓度下对东方粘虫(Mythimna separataWalker)具有一定的杀虫活性,尤其是N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)乙酰胺(8a)和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3-氯-2,2-二甲基丙酰胺(8e)致死率可达70%;部分化合物在50 mg·L^-1浓度下对油菜菌核病菌的抑菌活性相对较好(54.5%~63.6%),优于triadimefon和chlorantraniliprole;部分化合物如N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3,3-二甲基丁酰胺80和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-4-氟苯甲酰胺(8h)对苹果轮纹病菌具有中等抑菌活性.值得注意的是,化合物8e的杀粘虫活性和对油菜菌核病菌的抑菌活性都较为突出,可用作新农药创制研究的新型参考结构.     

新型N-取代苯基-2-吡唑基烟酰胺类化合物的合成及其生物活性

基于含吡啶基吡唑的邻甲酰氨基苯甲酰胺类农药分子结构,采用"酰基移位"的策略,以2-氯-3-氰基吡啶和4-溴吡唑或3,5-二甲基吡唑为起始原料,简便合成了14个结构新颖的N-取代苯基-2-吡唑基烟酰胺类目标化合物.通过1H NMR、13CNMR和HRMS对新化合物进行了结构表征.初步生物活性测试结果表明,目标化合物在200mg/L浓度下大多具有明显的杀虫活性,其中N-[4-氯-2-(乙氨基甲酰基)-6-甲基苯基]-2-(3,5-二甲基-1H-吡唑-1-基)烟酰胺(Il)对东方粘虫(MythimnaseparataWalker)具有70%的致死率;部分化合物在50mg/L浓度下对苹果轮纹病菌(Physalospora piricola)和番茄早疫病菌(AlternariasolaniSorauer)表现出较好的杀菌活性,其中2-(4-溴-1H-吡唑-1-基)-N-[2-(环丙氨基甲酰基)-4-碘-6-甲基苯基]烟酰胺(If)和2-(4-溴-1H-吡唑-1-基)-N-[4-氯-2-(乙氨基甲酰基)-6-甲基苯基]烟酰胺(Ih)对苹果轮纹病菌的抑制率分别达到62.9%和54.3%,2-(4-溴-1H-吡唑-1-基)-N-[4-氯-2-(正丙氨基甲酰基)苯基]烟酰胺(Id)对番茄早疫病菌具有54.5%的抑制率.研究结果为今后新型2-吡唑基烟酰胺类衍生物的深入研究提供了重要参考信息.     

新型2，6-双（3，5-二取代吡唑基-1-羰基）吡啶的合成

报道了四种吡唑衍生物和它们四种新型的杂环酰胺衍生物的合成，它们是3，5-二甲基吡唑(1)，5-甲基-3-苯基吡唑(2)，3，5-二苯基吡唑(3)，5-甲基-3-二茂铁基吡唑(4)，2，6-双(3，5-二甲基吡唑基-1-羰基)吡啶(5)，2，6-双(5-甲基-3-苯基吡唑基-1-羰基)吡啶(6)，2，6-双(3，5-二苯基吡唑基-1-羰基)吡啶(7)和2，6-双(5-甲基-3-二茂铁基吡唑基-1-羰基)吡啶(8)．并对它们进行了元素分析，FT-IR，^1H NMR和^13C NMR等波谱分析．     

水溶性稠杂环均三唑并噻二唑体系的合成及生物活性(I): 哌嗪取代衍生物

4-氨基-5-吡啶-4-基-均三唑硫醇(1)在复合催化剂DMAP和TBAB作用下与对卤代苯甲酸经环缩合反应以高收率得到中间体6-(5-氯-3-甲基-1-取代苯基-1H-吡唑-4-基)-3-吡啶-3-基-均三唑并[3,4-b][1,3,4]噻二唑(2a～2c), 接着苯环卤原子与取代哌嗪在聚乙二醇催化作用下发生亲核取代反应得到相应的哌嗪游离碱(3a～3c). 其中, 单取代哌嗪游离碱3a与含功能基的卤代物缩合得到功能基取代的哌嗪衍生物(4a～4g). 这些产生的游离碱与盐酸反应得到相应的水溶性盐酸盐. 所合成新化合物的结构经元素分析和光谱数据表征, 并评价了它们的体外抗菌活性及构效关系.     

5-氨基吡唑及5-氨基三唑类成纤维细胞生长因子受体激酶抑制剂的设计合成

成纤维细胞生长因子受体(FGFR)是近年来抗肿瘤靶向治疗药物研发的前沿热点.本研究以Debio1347为先导化合物,依据其与FGFR蛋白的对接结果,设计并合成了11个5-氨基吡唑及5-氨基-1,2,3-三唑类FGFR抑制剂.测定了化合物对受体酪氨酸激酶FGFR2以及FGFR2依赖型胃癌细胞株(SNU16)的体外抑制活性,并对其构效关系进了初步的探讨.其中,1-[5-氨基-1-(2-甲基-1H-苯并[d]咪唑-6-基)-1H-吡唑-4-基]-1-(1H-噻吩并[3,2-b]吡咯-2-基)甲酮(8)与1-[5-氨基-1-(2-甲基-1H-苯并[d]咪唑-6-基)-1H-1,2,3-三唑-4-基]-1-(1H-吲哚-2-基)甲酮(18)在酶水平上表现出了与Debio1347(3.5 nmol·L-1)相近的活性,其IC50值分别为3.3,2.3 nmol·L-1;在细胞水平上,化合物8和18与Debio1347(37.7 nmol·L-1)相比较活性略微降低,其IC50值分别为77.3,155.2 nmol·L-1.     

Synthesis of New Pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidines and Their Use in the Preparation of Tetraheterocyclic Systems

8,10-Dimethyl-3-(unsubstituted, methyl, ethyl, n-butyl, phenyl)-4-hydroxypyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-ones and 3-(2-hydroxyethyl)-2,8,10-trimethylpyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-4-ol were synthesized by cyclocondensation of 3-amine-4,6-dimethyl-1H-pyrazolo[3,4-b]pyridine with ethyl malonates and α-acetyl-γ-butyrlolactone. Dichloro- and diazido- derivatives were obtained from the reaction of pyridopyrazlopyrimidine derivatives with POCl₃ followed by NaN₃. The tetrahetrocyclic systems were formed by cyclization of 4-chloro-3-(2-chloroethyl)-2,8,10-trimethylpyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidine with the appropriate primary amines. The structures of all compounds were established by NMR and mass spectra.     

Optimized scale up of 3-pyrimidinylpyrazolo[1,5-a]pyridine via Suzuki coupling; a general method of accessing a range of 3-(hetero)arylpyrazolo[1,5-a]pyridines

We have developed an improved synthesis of 3-(hetero)aryl pyrazolo[1,5-a]pyridines (such as 3-(2,5-dichloropyrimidin-4-yl)pyrazolo[1,5-a]pyridine (8)) via an optimized synthesis and Suzuki coupling of 3-pyrazolo[1,5-a]pyridine boronic ester 10. These conditions are applicable to both high throughput chemistry and large scale synthesis of these medicinally important compounds. The scope of this chemistry has been further extended to include the synthesis and coupling of a novel boronic ester, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine (43).     

Synthesis of Pyrido[2′,3′: 3,4]pyrazolo[1,5‐a]pyrimidine,Pyrido[2′,3′:3,4]pyrazolo[5,1‐c][1,2,4]triazine,and Pyrazolyl Oxadiazolylthieno[2,3‐b]pyridine Derivatives

6‐(2‐Thienyl)‐4‐(trifluoromethyl)‐1H‐pyrazolo[3,4‐b]pyridine‐3‐amine reacted with different active methylene compounds to afford pyridopyrazolopyrimidine derivatives. On the other hand, it reacted with some halo compounds to give the imidazo[1′,2′:1,5]pyrazolo[3,4‐b]pyridine derivatives. Also, it diazotized to give the corresponding diazonium chloride that is coupled with several active methylene compounds to give the corresponding triazine derivatives. Furthermore, compound 3‐amino‐6‐(2(thienyl)‐4‐(trifluoromethyl)thieno[2,3‐b]pyridine‐2‐carbohydrazide reacted with some β‐dicarbonyl compounds and some sulfur‐containing compounds to afford the corresponding pyrazolyl oxadiazolylthieno[2,3‐b]pyridine derivatives.     

Acid-catalyzed reactions of 3-(hydroxymethyl)- and 3-(1-hydroxyethyl)pyrazolo[1,5-a]pyridines

Treatment of 3-(hydroxymethyl)pyrazolo[1,5-a]pyridines with trifluoroacetic acid in refluxing dichloro-methane led to the formation of bis(pyrazolo[1,5-a]pyrid-3-yl)methanes or bis[(pyrazolo[1,5-a]pyrid-3-yl)]-methyl ethers depending upon the concentration of trifluoroacetic acid. In contrast, similar treatment of 3-(1-hydroxyethyl)pyrazolo[1,5-a]pyridines gave a mixture of 3-vinylpyrazolo[1,5-a]pyridines and 1,3-bis(pyrazolo-[1,5-a]pyrid-3-yl)-1-butenes.     

α-aminoazoles in synthesis of heterocycles: IV. Regiodirection of 3(5)-amino-5(3)-methylpyrazole reaction with hexafluoroacetylacetone

The reaction of 3(5)-amino-5(3)-methylpyrazole with hexafluoroacetylacetone depending on the process conditions led to the formation either of pyrazolo[1,5-a]pyrimidine or pyrazolo[3,4-b]-pyridine. By means of 2D NMR spectroscopy the structure was established of a stable intermediate product, 2-methyl-5,7-bis(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]-pyrimidine-5,7-diol, whose dehydration yielded the above compounds.     

Synthesis of condensed tricyclic pyrazolo[3,4-b]thieno[2,3-d]pyridine and related isostere derivatives

In this paper we report the synthesis of an isosteric series of new heterotricyclic derivatives, corresponding to pyrazolo[3,4-b]thieno[2,3-d]pyridine ( 1 ), pyrazolo[3,4-b]furano[2,3-d]pyridine ( 2 ) and pyrazolo[3,4-b]pyrrolo[2,3-d]pyridine ( 3 ). These functionalized compounds were obtained, in high overall yield, by an ‘one-pot’ reaction of the chloroester intermediate 4 , possessing the pyrazolo[3,4-b]pyridine system, with an adequate α-hetero-acetyl ester derivative, in SNAr/Dieckman cyclization type consecutive reactions.     

Au(i)-catalyzed and iodine-mediated cyclization of enynylpyrazoles to provide pyrazolo[1,5-a]pyridines

Pyrazolo[1,5-a]pyridines and 6-iodopyrazolo[1,5-a]pyridines were synthesized by gold-catalyzed and iodine-mediated cyclization of enynylpyrazoles in good to excellent yields, respectively. The iodinated adducts were further converted to 6-arylpyrazolo[1,5-a]pyridines via Suzuki-Miyaura coupling reaction and 6-cyanopyrazolo[1,5-a]pyridine by Ullmann condensation reaction. One of the cyclization adducts, 2-(4-fluorophenyl)pyrazolo[1,5-a]pyridine, was converted to a p38 kinase inhibitor, 2-(4-fluorophenyl)-3-(4-pyridinyl)pyrazolo[1,5-a]pyridine, in two steps.     

Reactions of pyridinium or isoquinolinium ketene dithioacetals with aromatic N-imines and S-imines

Reactions of ketene dithioacetals, 1-[1-substituted 2,2-bis(methylthio)ethenyl]pyridinium 1a-i or -isoquinolinium 2a,b iodides with aromatic N-imines, 1-aminopyridinium 3a-1,1 -aminoquinolinium ( 4 ), and 2-amino-isoquinolinium ( 5 ) mesitylene sulfonates gave the corresponding 2-methylthioimidazo[1,2-a]pyridines 9a-k , 2-methylthiopyrazolo[1,5-a]pyridines 11a-q , 2-methylthioimidazo[2,1-a]isoquinoline derivatives 10a,b and 2-methylthiopyrazolo[1,5-a]quinoline ( 12 ). The benzoyl compounds, 1-[1-benzoyl-2,2-bis(methylthio)ethenyl]-pyridinium iodides 1g,h,i reacted with N-imine 3a to give the 3-benzoyl-2-methylthioimidazo[1,2-a]pyridines 9h-k . The reaction of pyridinium ketene dithioacetals 1a,f,g (R¹ = COOE_t, COPh, and CN) with substituted pyridinium N-imines having an electron-withdrawing group on the pyridine ring afforded only the corresponding pyrazolo[1,5-a]pyridine derivatives 11j-r in good yields. Reactions of ketene dithioacetals with various S-imines are also described. Possible mechanisms for the formation of 9 and 11 are described.     

Aminopyrazoles. Part 3. Synthesis of the novel ring systems pyrazolo[4′,3′:5,6]pyrido[2,3-b][1,5]benzoxazepine and [1,5]benzothiazepine

Two-step synthesis of the novel fused heterocycles pyrazolo[4′,3′:5,6]pyrido[2,3-b][1,5]benzoxazepine ( 8 ) and pyrazolo[4′,3′:5,6]pyrido[2,3-b][1,5]benzothiazepine ( 9 ) from the pyrazolo[3,4-b]pyridine derivative 1 is described.     

Green One‐Pot Solvent‐Free Synthesis of Pyrazolo[1,5‐a]pyrimidines,Azolo[3,4‐d]pyridiazines,and Thieno[2,3‐b]pyridines Containing Triazole Moiety

Synthesis of pyrazolo[1,5‐a]pyrimidines, [1,2,4]triazolo[1,5‐a]pyrimidine, 8,10‐dimethyl‐2‐(5‐methyl‐1‐phenyl‐4,5‐dihydro‐1H‐1,2,3‐triazol‐4‐yl)pyrido[2′,3′:3,4]‐pyrazolo[1,5‐a]pyrimidine, benzo[4,5]imidazo[1,2‐a]pyrimidine via heterocyclic amines, and sodium 3‐hydroxy‐1‐(5‐methyl‐1‐phenyl‐1H‐1,2,3‐triazole‐4‐yl)prop‐2‐en‐1‐one were carried out. Also, synthesis of isoxazoles, and pyrazoles from sodium 3‐hydroxy‐1‐(5‐methyl‐1‐phenyl‐1H‐1,2,3‐triazole‐4‐yl)prop‐2‐en‐1‐one and hydroxymoyl chlorides and hydrazonoyl halides, respectively, were made. Analogously, (1,2,3‐triazol‐4‐yl)thieno[2,3‐b]pyridine derivatives were obtained from sodium 3‐hydroxy‐1‐(5‐methyl‐1‐phenyl‐1H‐1,2,3‐ triazole‐4‐yl)prop‐2‐en‐1‐one and cyanothioacetamide followed by its reacting with active methylene compounds. In addition to full characterization of all synthesized compounds, they were tested to evaluate their antimicrobial activities, and some compounds showed competitive activities to those of tetracycline, the typical antibacterial drug, and clotrimazole, the typical antifungal drug.